Viewing StudyNCT00287222



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00287222
Status: COMPLETED
Last Update Posted: 2011-07-15
First Post: 2006-02-03

Brief Title: Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
Sponsor: University of Arkansas
Organization: University of Arkansas

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-02
Start Date Type: None
Primary Completion Date: 2010-09
Primary Completion Date Type: ACTUAL
Completion Date: 2010-09
Completion Date Type: ACTUAL
First Submit Date: 2006-02-03
First Submit QC Date: February 3 2006
Study First Post Date: 2006-02-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2011-07-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-06-17
Last Update Post Date: 2011-07-15
Last Update Post Date Type: ESTIMATED